| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |